C1GalT1-mediated truncation of O-glycans on CD44 inactivates the ERK/NF-κB signaling pathway, resulting in NANOG expression in pancreatic cancer (PC) cells and changes in tumor stem cell characteristics. The gene discussed is NFKB1; the disease is neoplasm.